Advanced search
Publication Cover
Reproductive Health Matters
An international journal on sexual and reproductive health and rights
Volume 12, 2004 - Issue 24: Power, money and autonomy in national policies and programmes
Submit an article Journal homepage
316
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Where Are We Now with Hormone Replacement Therapy?

Klim McPhersonVisiting Professor of Public Health Epidemiology, Nuffield Department of Obstetrics and Gynaecology, Research Institute, Churchill Hospital, Oxford, [email protected]
Pages 200-203 | Published online: 30 Oct 2004

References

  • E Barrett-Connor. Cardiovascular endocrinology 3: an epidemiologist looks at hormones and heart disease in women. J Clin End Met. 88: 2003; 4031–4042.
  • Writing Group for Women's Health Initiative Investigators. Risks and benefits of estrogen and progestin in healthy postmenopausal women: principal results from the women's health initiative randomised controlled trial. JAMA. 288: 2002; 321–333.
  • Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the million women study. Lancet. 362: 2003; 419–427.
  • J Studd. Complications of hormone replacement therapy in postmenopausal women. J R Soc Med. 85: 1992; 376–378.
  • KB Michels, JE Manson. Postmenopausal hormone therapy, a reversal of fortune. Circulation. 107: 2003; 1830–1833.
  • D Sackett. The arrogance of preventive medicine. JCMA. 167: 2002; 363–364.
  • DM Herrington, TD Howard. From presumed benefit to potential harm–hormone therapy and heart disease. N Engl J Med. 346: 2003; 519–521.
  • J Bailar. Hormone replacement therapy and cardiovascular diseases. N Engl J Med. 339;6: 2003; 521–522.
  • C Minelli, KK Abrams, AJ Sutton, NJ Cooper. Benefits and harms associated with hormone replacement therapy: clinical decision analysis. BMJ. 328: 2004; 371–375.
  • S Shapiro. Risks of estrogen plus progestins therapy; a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial. Climacteric. 6: 2003; 302–310.
  • JE Manson, J Hsia, KC Johnson, JE Rossouw, AR Assaf, NL Lasser. Estrogen plus progestins and the risks of coronary heart disease. N Engl J Med. 349: 2003; 523–534.
  • G Tucker. Comments from reviewer. Climacteric. 6: 2003; 310–314.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.